Sarmad Sadeghi, Laurence Albiges, Laura S. Wood, Shari L. Black, Timothy D. Gilligan, Robert Dreicer, Jorge A. Garcia, Bernard J. Escudier and Brian I. Rini Cessation of vascular endothelial growth factor–targeted therapy in patients with metastatic renal cell carcinoma Cancer 118
Version of Record online: 2 DEC 2011 | DOI: 10.1002/cncr.26666
A select subset of patients with metastatic renal cell carcinoma who achieved stable disease or better on vascular endothelial growth factor–targeted therapy can be observed off all therapy. Further prospective investigation is warranted.
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field